---
title: "Stroke Drugs Ref - Reviews, Revenue and Downloads in Türkiye | Apple App Store"
description: "IMPORTANT: This app is intended for use by qualified healthcare professionals only. Always seek the advice of a qualified clinician before making any medical or prescribing decisions.  Stroke Drugs Re"
---

# Stroke Drugs Ref — Türkiye

![Stroke Drugs Ref App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/2c/2d/77/2c2d7723-9f8f-0b29-92c7-f6d54d92e769/AppIcon-0-0-1x_U007epad-0-1-85-220.png/434x0w.png)

**Developer:** [ATIF ELNIL](https://apptail.io/developer/atif-elnil-aKJsNb)
**Category:** Medical
**Rating:** N/A (0 ratings)
**Price:** Free
**Bundle ID:** com.atifelnil.Stroke-Drugs-Ref
**Store:** Apple App Store
**Country:** Türkiye
**Version:** 1.0 (released 2026-03-28)
**Original Release:** 2026-04-01
**Languages:** English

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/tr/app/app/id6761284777)
**AppTail Page:** [https://apptail.io/app/stroke-drugs-ref-ttvz/turkey](https://apptail.io/app/stroke-drugs-ref-ttvz/turkey)

## Stroke Drugs Ref Description
IMPORTANT: This app is intended for use by qualified healthcare professionals only. Always seek the advice of a qualified clinician before making any medical or prescribing decisions.

Stroke Drugs Ref is a comprehensive evidence-based stroke pharmacology reference for neurologists, stroke physicians, emergency doctors, nurses and allied health professionals. Built for the stroke unit, emergency department and outpatient clinic.

THROMBOLYSIS
Complete alteplase and tenecteplase protocols with dosing calculators:
- Alteplase: 0.9 mg/kg IV (max 90mg) - bolus and infusion protocol
- Tenecteplase: 0.25 mg/kg IV bolus - AcT trial 2022, now preferred in many centres
- Eligibility criteria including wake-up stroke (WAKE-UP trial) and extended window (EXTEND trial)
- Absolute and relative contraindications with risk-benefit guidance
- Complications: symptomatic ICH reversal protocol, angioedema management

ANTIPLATELET THERAPY
- Aspirin 300mg acute loading - IST/CAST evidence
- DAPT protocol: aspirin + clopidogrel 21 days for TIA/minor stroke (POINT, CHANCE, THALES trials)
- Clopidogrel - NICE NG128 preferred long-term agent, CYP2C19 interaction guidance
- Ticagrelor: THALES trial, CYP2C19-independent, dyspnoea counse

Dr Atif Elnil MBBS MRCP Neurology St Georges London UK

## Stroke Drugs Ref Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/90/29/dd/9029dde5-765f-929f-a14d-350756085f1e/iphone_01_home.png/1242x2688.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/3a/f4/2d/3af42dcc-747a-2d4e-5741-f620b44b4bc7/iphone_03_antiplatelets.png/1242x2688.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/77/a7/f9/77a7f914-4ac0-f93b-e511-0c924a2c7845/iphone_04_doacs.png/1242x2688.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/7d/f7/6f/7df76fcb-e204-569e-cbb4-a8bff3155d58/iphone_02_thrombolysis.png/1242x2688.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/72/33/72/7233723a-7975-5e1a-0696-03020ab0e23a/iphone_09_af.png/1242x2688.png)
- [Screenshot 6](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/e2/42/3a/e2423ac4-d92c-edcc-c65f-72a85eb9b0ef/iphone_06_bp.png/1242x2688.png)
- [Screenshot 7](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/24/a5/cc/24a5ccbd-c83a-24a0-bb77-e65b8b0aa7c3/iphone_07_lipids.png/1242x2688.png)
- [Screenshot 8](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/b0/16/cd/b016cd05-7b7e-b9c0-3e81-14ffc6179229/iphone_08_secondary.png/1242x2688.png)
- [Screenshot 9](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/c2/4d/43/c24d43ea-d5ae-735b-15f5-192930af6bdd/iphone_05_reversal.png/1242x2688.png)
- [Screenshot 10](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/2f/84/7e/2f847e4d-3fe7-ef55-dccd-ed9e10bf3994/iphone_10_sources.png/1242x2688.png)







## Stroke Drugs Ref Available In
- [Japan](https://apptail.io/app/stroke-drugs-ref-ttvz/japan)
- [Türkiye](https://apptail.io/app/stroke-drugs-ref-ttvz/turkey)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://apptail.io/account/signup?utm_campaign=ai-crawl&utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*